BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21837480)

  • 1. Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients.
    Cho YH; Shen J; Gammon MD; Zhang YJ; Wang Q; Gonzalez K; Xu X; Bradshaw PT; Teitelbaum SL; Garbowski G; Hibshoosh H; Neugut AI; Chen J; Santella RM
    Breast Cancer Res Treat; 2012 Jan; 131(1):197-205. PubMed ID: 21837480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.
    Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R
    Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene promoter methylation is associated with increased mortality among women with breast cancer.
    Xu X; Gammon MD; Zhang Y; Cho YH; Wetmur JG; Bradshaw PT; Garbowski G; Hibshoosh H; Teitelbaum SL; Neugut AI; Santella RM; Chen J
    Breast Cancer Res Treat; 2010 Jun; 121(3):685-92. PubMed ID: 19921426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Borderline and malignant phyllodes tumors display similar promoter methylation profiles.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
    Virchows Arch; 2009 Dec; 455(6):469-75. PubMed ID: 19924440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation modifies the association between obesity and survival after breast cancer diagnosis.
    McCullough LE; Chen J; Cho YH; Khankari NK; Bradshaw PT; White AJ; Garbowski G; Teitelbaum SL; Terry MB; Neugut AI; Hibshoosh H; Santella RM; Gammon MD
    Breast Cancer Res Treat; 2016 Feb; 156(1):183-94. PubMed ID: 26945992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA2 carriers with male breast cancer show elevated tumour methylation.
    Deb S; Gorringe KL; Pang JB; Byrne DJ; Takano EA; ; Dobrovic A; Fox SB
    BMC Cancer; 2017 Sep; 17(1):641. PubMed ID: 28893223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.
    Sheng X; Guo Y; Lu Y
    Medicine (Baltimore); 2017 Jul; 96(28):e7476. PubMed ID: 28700487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women.
    Lee JS; Lo PK; Fackler MJ; Argani P; Zhang Z; Garrett-Meyer E; Sukumar S
    Cancer Biol Ther; 2007 Jul; 6(7):1114-20. PubMed ID: 17611401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
    Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer.
    Xu X; Gammon MD; Zhang Y; Bestor TH; Zeisel SH; Wetmur JG; Wallenstein S; Bradshaw PT; Garbowski G; Teitelbaum SL; Neugut AI; Santella RM; Chen J
    Breast Cancer Res Treat; 2009 May; 115(2):397-404. PubMed ID: 18521744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
    Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
    Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.
    Fackler MJ; McVeigh M; Evron E; Garrett E; Mehrotra J; Polyak K; Sukumar S; Argani P
    Int J Cancer; 2003 Dec; 107(6):970-5. PubMed ID: 14601057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer.
    Vu TL; Nguyen TT; Doan VTH; Vo LTT
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1887-1893. PubMed ID: 30049201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes.
    Van der Auwera I; Bovie C; Svensson C; Limame R; Trinh XB; van Dam P; Van Laere SJ; Van Marck E; Vermeulen PB; Dirix LY
    Cancer Biol Ther; 2009 Dec; 8(23):2252-9. PubMed ID: 19829046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene methylation in breast ductal fluid from BRCA1 and BRCA2 mutation carriers.
    Antill YC; Mitchell G; Johnson SA; Devereux L; Milner A; Di Iulio J; Lindeman GJ; Kirk J; Phillips KA; Campbell IG
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):265-74. PubMed ID: 20056647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review.
    de Ruijter TC; van der Heide F; Smits KM; Aarts MJ; van Engeland M; Heijnen VCG
    Breast Cancer Res; 2020 Jan; 22(1):13. PubMed ID: 32005275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter CpG island hypermethylation during breast cancer progression.
    Park SY; Kwon HJ; Lee HE; Ryu HS; Kim SW; Kim JH; Kim IA; Jung N; Cho NY; Kang GH
    Virchows Arch; 2011 Jan; 458(1):73-84. PubMed ID: 21120523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.